NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
Sign Up to like & getrecommendations! Published in 2018 at "Neuropharmacology"
DOI: 10.1016/j.neuropharm.2017.11.045
Abstract: &NA; Negative and cognitive deficit symptoms in schizophrenia remain an unmet clinical need. Improved understanding of the neuro‐ and psychopathology of cognitive dysfunction in the illness is urgently required to enhance the development of new… read more here.
Keywords: cognition schizophrenia; rodent; effects nmdar; antagonist ... See more keywords